CeriBell (NASDAQ:CBLL) CEO Xingjuan Chao Sells 6,068 Shares

CeriBell, Inc. (NASDAQ:CBLL) CEO Xingjuan Chao sold 6,068 shares of CeriBell stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $24.02, for a total transaction of $145,753.36. Following the completion of the transaction, the chief executive officer owned 781,731 shares of the company’s stock, valued at $18,777,178.62. This trade represents a 0.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Xingjuan Chao also recently made the following trade(s):

• On Wednesday, August 19th, Xingjuan Chao sold 31,415 shares of CeriBell stock. The stock was sold at an average price of $25.03, for a total value of $786,317.45.
• On Tuesday, August 18th, Xingjuan Chao sold 2,199 shares of CeriBell stock. The shares were sold at an average price of $25.00, for a total transaction of $54,975.00.
• On Tuesday, July 7th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The shares were sold at an average price of $19.90, for a total value of $776,100.00.
• On Monday, June 8th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The shares were sold at an average price of $18.33, for a total transaction of $714,870.00.

CeriBell Stock Performance

Shares of CBLL stock traded up $0.01 during mid-day trading on Tuesday, hitting $23.95. The stock had a trading volume of 243,381 shares, compared to its average volume of 457,237. The company has a debt-to-equity ratio of 0.16, a current ratio of 9.18 and a quick ratio of 8.79. The firm has a market cap of $919.20 million, a PE ratio of -13.61 and a beta of 0.81. CeriBell, Inc. has a fifty-two week low of $10.85 and a fifty-two week high of $25.33. The company’s 50-day simple moving average is $19.77 and its 200-day simple moving average is $19.27.

CeriBell (NASDAQ:CBLL) last announced its quarterly earnings data on Monday, August 10th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.04). CeriBell had a negative net margin of 64.73% and a negative return on equity of 44.85%. The company had revenue of $28.10 million during the quarter, compared to analyst estimates of $27.28 million. Sell-side analysts anticipate that CeriBell, Inc. will post -1.96 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CBLL shares. BTIG Research upped their target price on CeriBell from $28.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, August 18th. Weiss Ratings upgraded CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, August 13th. Barclays upgraded shares of CeriBell to a “neutral” rating in a report on Tuesday, August 18th. Finally, Canaccord Genuity Group boosted their price objective on shares of CeriBell from $25.00 to $26.00 and gave the company a “buy” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $22.40.

Institutional Investors Weigh In On CeriBell

Hedge funds have recently modified their holdings of the stock. Russell Investments Group Ltd. increased its position in CeriBell by 41.4% during the fourth quarter. Russell Investments Group Ltd. now owns 2,918 shares of the company’s stock worth $64,000 after purchasing an additional 854 shares during the last quarter. Sei Investments Co. raised its stake in CeriBell by 2.3% during the first quarter. Sei Investments Co. now owns 50,360 shares of the company’s stock worth $923,000 after purchasing an additional 1,125 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in shares of CeriBell by 3,971.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock valued at $28,000 after purchasing an additional 1,231 shares during the last quarter. Deutsche Bank AG grew its stake in shares of CeriBell by 1.7% during the 4th quarter. Deutsche Bank AG now owns 85,182 shares of the company’s stock valued at $1,868,000 after buying an additional 1,393 shares during the period. Finally, Strs Ohio purchased a new stake in shares of CeriBell during the 1st quarter valued at $27,000.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.